NASDAQ:BDSI
Delisted

Biodelivery Sciences International Stock News

etoro logo Buy BDSI
*Your capital is at risk
$5.59
+0 (+0%)
At Close: May 27, 2022
The world needs more than one vaccine to tackle the new coronavirus, even as pharma companies race to be the first with a pandemic shot, the infectious-disease expert says.
Top U.S. health officials told lawmakers Thursday they're pursuing multiple technologies to develop a COVID-19 vaccine that could cut months off the normal time it takes to get it to market.
A trial evaluating its most advanced drug has been discontinued because of a lack of efficacy.
The U.S. recorded the highest number of new cases of the coronavirus illness COVID-19 in a single day at more than 50,000 on Wednesday, according to data...
HHS said it had acquired all the supplies of the drug for July and 90% of supplies for August and September. Many developing countries have access to generic versions, but WTO rules could complicate t
Metric Capital Partners LLP is looking for more deals in Turkey after investing more in the country’s manufacturing industry than any other international private-equity company over the past two yea
Dr. Anthony Fauci, the United States' top-ranking infectious diseases expert, said Thursday there's a risk of an even larger spread of COVID-19 unless a recent wave of new cases are brought under cont
Cornell plans to spend $3 million to $5 million to "mandate testing, and tracing and isolation, on a very aggressive regular basis," University President Martha Pollack told CNBC.
A federal appeals court upheld two key patents covering Amgen's Enbrel, thus further preventing Novartis' generics unit from launching its biosimilar. However, an analyst wrote that the probability of
"This will be over by January one way or the other," former FDA Commissioner Dr. Scott Gottlieb said on "Squawk Box."
The U.S. may not see a coronavirus vaccine until next year, FDA Commissioner Stephen Hahn said as an increasing number of Americans say they would get the shot.
Analysts said it is far from a sure thing that Pfizer and its partner, BioNTech, will be able to win FDA approval as quickly as they indicated they might.
Our call of the day has charted out some highs and lows for the S&P 500 that investors need to watch out for in coming weeks and months. And here’s what...
As the weeks go by, the timeline for a coronavirus vaccine is getting shorter and driving optimism.
The world needs more than one vaccine to tackle the new coronavirus, even as pharma companies race to be the first with a pandemic shot, said US infectious-disease expert Anthony Fauci.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE